Replies to post #27391 on Relief Therapeutics Holding AG (RLFTF)

[nelskof]

What specific questions do you have?

The company is going 'all-in' with the interim review at the 102nd patient that was enrolled 9/30. The data will be available to the board after 10/28.

It's very similar to the other company you are with in that they want to file an EUA based on 2b data. That will open the world to the drug.

It's really simple as that. If that data is overwhelming then it's all systems go. If it's not, then shut it down.

You can look to studies done in Brazil that backs the science, similar to the UT Dallas studies you should be familiar with on other drug.

Anything else?

Should have mentioned they already filed for EUA for critical patients based on the science and Expanded Access Protocol patients. We're still waiting to hear about that one.

[tiggerifficm4]

You raise good points here.

Sometimes we all get a bit excited about our new beautiful baby, only to find out it's as ugly as we are. Just kidding....

But in my opinion it's good to have fresh, critical eyes to point out possible issues and let those who believe(me included) defend our position.

I have spoken to two folks at Relief, one for about an hour. Both told me their story and other antidotal things. Unless they just mess up something, it's a very sincere group of people.

Just keep politics out, does no good unless specific ties to the treatment or companies involved.

Everyone wants to see this treatment approved to save lives and as a bonus provide a bit of money.

[aGuyUS]

Well I for one appreciate well documented posts. Not random assertions that sound like assumptions pulled from a person's arse. This post was at least somewhat thought out.

You are correct these are all Red Flags you point out. They are definitely considerations for more contemplation over an investment.

Probably something you want to read over is this document.

https://docs.google.com/document/d/1CboxDEE1uR4C0DsgXlsQ_01IfO3o45Oq0Chi712QuP0/edit?usp=sharing

I'd concentrate on a few videos on the Drug itself RLF-100 a synthetic drug in the form of Vasoactive Intestinal Peptide and what it does...because that product is what we are predominantly discussing. THEN, look at the OSwald Cruz foundation in Brazil Research paper on VIP and SAR-CoV-2 (COVID19) and how VIP inhibits COVID19 in that study

That is where I derive my assurances for the lack of trial patients and questions about enrollment in the study...and why I am not bothered by Javitt's commentaries on the drug.

As far as Reckless, he is a man of Science. It is Rare in Science you get a slam dunk. If Relief and NeuroRX are correct and these Clinical trials prove such.... THIS is the equivalent of landing a man on the moon in 1963. If he sounds excited about I am willing to allow him his moment.

As far as who he reminds me of????????? I cannot read your mind...but if you are insinuating he is reminding you of Trump? I would entirely disagree with that assumption. I find him more than humble, willing to credit people for their work so much so he interrupts interviewers to make the distinctions and is always cognizant of placing the burden on Science not on his personal hopes or whims. He never leans out over his skis in interviews. He is a straight shooter with a kind and gracious demeanor, In my assessment of him.